SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-008869
Filing Date
2021-04-15
Accepted
2021-04-15 16:14:04
Documents
63
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1674203
2 ex4-3.htm EX-4.3 19520
3 ex21.htm EX-21 1741
4 ex23-1.htm EX-23.1 3988
5 ex31-1.htm EX-31.1 16671
6 ex31-2.htm EX-31.2 17359
7 ex32.htm EX-32 7965
8 image_01.jpg GRAPHIC 14584
  Complete submission text file 0001493152-21-008869.txt   6778214

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE rspi-20201231.xml EX-101.INS 1147651
10 XBRL SCHEMA FILE rspi-20201231.xsd EX-101.SCH 68975
11 XBRL CALCULATION FILE rspi-20201231_cal.xml EX-101.CAL 48757
12 XBRL DEFINITION FILE rspi-20201231_def.xml EX-101.DEF 298205
13 XBRL LABEL FILE rspi-20201231_lab.xml EX-101.LAB 481488
14 XBRL PRESENTATION FILE rspi-20201231_pre.xml EX-101.PRE 359883
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16467 | Film No.: 21828628
SIC: 2834 Pharmaceutical Preparations